The Role of Ga-68-FAPI PET/CT for Malignancies of the Lower GI Tract
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
The month of September represents the prostate cancer, thyroid cancer, [...]
64Cu-Diasparagine (64CuASP) is a 64Cu-labeled peptide developed for the imaging [...]
67Cu-SARTATE (67Cu-SAR-[Tyr3]-Octreotate) is a therapeutic radiolabeled somatostatin analogue of [...]
177Lu-PSMA-R2 was developed as patent protected equivalent of 177Lu-PSMA-617. This [...]
177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]
177Lu-DOTA-EB-TATE is a theranostic agent based on octreotate that uses [...]
177Lu-Debio 1124 is a second-generation radiolabeled peptide analogue of minigastrin [...]
177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]
131I-RPS-001 (131I-MIP-1095) is a small radiolabeled molecule, a glutamate-urea-lysine analogue, [...]